StockData
CURLFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Curaleaf Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$7.63−0.20 (-2.55%)

Close on Oct 19, 2026

Market cap
$2.07B
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 6, 2026After market close$340.00M$0.05–

Press releases

Announcements Curaleaf filed with the SEC